CEO Tim Dyer Addex is getting a CHF 5 million ($5.5 million) payment in return for the allosteric modulator candidates and discovery platform and will hold a 20% stake in the new company ...

53 LR Geneva, Switzerland, July 1, 2024 - Addex Therapeutics (SIX: ADXN and Nasdaq: ADXN), a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and ...

Unconscious Bias Test: Test yourself—Project Implicit, Implicit Association Test IAT. This is an online test of quick responses to a series of words and pictures; the test measures response time to ...

Under the amended agreement, Neurocrine will obtain exclusive rights for all indications to develop and commercialize osavampator, a potential first-in-class AMPA positive allosteric modulator in ...

The Diversity and Inclusion 360 Commission, a one-year presidential initiative established by past President Paulette Brown, explored the existence of implicit bias and what can be done to combat it ...